ForDoz Pharma has entered into an agreement with Lupin, to market and distribute two complex injectable products in advanced development stage at ForDoz, in the U.S. and its territories. The products are in the oncology and anti-infective therapeutic areas which when approved, will provide affordable alternatives to patients and healthcare professionals.   These two licensed products are flagship technology assets among ForDoz’ complex injectable product pipeline portfolio including, liposome, m...